German-Chinese ADC collaboration

BioNTech has entered the ADC field with an exclusive license and collaboration agreement with China’s DualityBio Ltd for two antibody-drug conjugate (ADC) assets.

Read more

LSP Dementia Fund closes at €260m

EQT Life Sciences has closed the LSP Dementia Fund at approximately €260m, 2.6-fold over the target fund size of €100m.

Read more

Hot of the press: new issue of BIOTECH Insight

The latest issue of BIOTECH Insight newsletter of Deutsche Börse in collaboration with BIOCOM AG is out, covering hot topics of the German biotech sector.

Read more

Algal enzyme synthesizes gasoline building blocks

An algal photoenzyme that synthesizes medium-chain hydrocarbons – the building blocks of gasoline – is set to boost industrial-scale production of biofuels.

Read more

Macomics licences macrophage modulator to Ono

Edinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer.

Read more

mbiomics GmbH cashes in €13m in Series A financing

Munich-based microbiome therapeutics specialist mbiomics GmbH has raised €13m in the first closing of Series A round led by MIG Capital.

Read more

500 experts at the 7th AMR Conference in Basel

How to stop hard-to-diagnose, treatment-resistant microbial pathogens was discussed by experts from 13 countries at the 7th AMR Conference in Basel.

Read more

Vitestro raises €12m in Series A financing

With assets of €12m through a Series A financing, Dutch Vitestro NV aims to bring the world’s first autonomous blood drawing device to the market.

Read more